An Cheng

10PUBLICATIONS
14CO-AUTHORS
PharmacogenomicsMedical biochemistry - lipidsNeurology and neuromuscular diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 29, 2026
Dopamine D2 Receptors, D1/D2 Receptor Heteromers and CaMKII Signaling in the Neurobiology of Drug Addiction.

|Oct 15, 2025
Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration.

Chuantao Wu, Jiejing Lin, Qikai Chen

|Apr 21, 2023
Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation.

An Cheng, Ichiro Kawahata, Yifei Wang

|Apr 13, 2023
Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors in Mice by an FABP3 Inhibitor.

Wenbin Jia, Ichiro Kawahata, An Cheng

|Sep 09, 2022
Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets.

Qingyun Guo, Ichiro Kawahata, An Cheng

|Jun 02, 2021
Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy.

An Cheng, Wenbin Jia, Ichiro Kawahata

Pageof 2

Frequent Collaborators

8 joint publications

Ichiro Kawahata

5 joint publications

Kohji Fukunaga

5 joint publications

Wenbin Jia

1 joint publications

Dian Yuan